The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Liposome‐encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis
Open accessAbstract
BACKGROUND: Because a role for nuclear factor‐κB (NF‐κB) has been implicated in the pathogenesis of pancreatic carcinoma, this transcription factor is a potential target for the treatment of this devastating disease. Curcumin (diferuloylmethane) is a phytochemical with potent NF‐κB‐inhibitory activity. It is pharmacologically safe, but its bioavailability is poor after oral administration. METHODS: The authors encapsulated curcumin in a liposomal delivery system that would allow intravenous administration. They studied the in vitro and in vivo effects of this compound on proliferation, apoptosis, signaling, and angiogenesis using human pancreatic carcinoma cells. NF‐κB was constitutively active in all human pancreatic carcinoma cell lines evaluated and liposomal curcumin consistently suppressed NF‐κB binding (electrophoretic mobility gel shift assay) and decreased the expression of NF‐κB‐regulated gene products, including cyclooxygenase‐2 (immunoblots) and interleukin‐8 (enzyme‐linked immunoassay), both of which have been implicated in tumor growth/invasiveness. These in vitro changes were associated with concentration and time‐dependent antiproliferative activity (3‐[4,5‐dimethylthiazol‐2‐yl]2,5‐diphenyltetrazolium bromide assay [MTT assay]) and proapoptotic effects (annexin V/propidium iodide staining [fluorescence‐activated cell sorting] and polyadenosine‐5′‐diphosphate‐ribose‐polymerase cleavage). RESULTS: The activity of liposomal curcumin was equal to or better than that of free curcumin at equimolar concentrations. In vivo, curcumin suppressed pancreatic carcinoma growth in murine xenograft models and inhibited tumor angiogenesis. CONCLUSIONS: Liposomal curcumin down‐regulated the NF‐κB machinery, suppressed growth, and induced apoptosis of human pancreatic cells in vitro. Antitumor and antiangiogenesis effects were observed in vivo. The experiments in the current study provide a biologic rationale for treatment of patients suffering from pancreatic carcinoma with this nontoxic phytochemical encapsulated in liposomes for systemic delivery. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Ammon, H., & Wahl, M. (1991) · Planta Medica · doi:10.1055/s-2006-960004 · Cited by 1,347
Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., & Takahashi, T. (1998) · PubMed · Cited by 818
Huang, M., Smart, R. C., Wong, C.-Q., & Conney, A. H. (1988) · PubMed · Cited by 729
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., & Sartor, R. B. (1999) · PubMed · Cited by 718
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., & Sartor, R. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3474 · Cited by 681
Rao, C. V., Rivenson, A., Simi, B., & Reddy, B. S. (1995) · PubMed · Cited by 676
Wang, W., Abbruzzese, J. L., Evans, D. B., Larry, L., Cleary, K. R., & Chiao, P. J. (1999) · PubMed · Cited by 651
Plummer, S. M., Holloway, K. A., Manson, M. M., Munks, R. J., Kaptein, A., Farrow, S., & Howells, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202980 · Cited by 628
Kawamori, T., Lubet, R., Steele, V. E., Kelloff, G. J., Kaskey, R. B., Rao, C. V., & Reddy, B. S. (1999) · PubMed · Cited by 589
Huang, M., Lysz, T. W., Ferraro, T., Abidi, T. F., Laskin, D. L., & Conney, A. H. (1991) · PubMed · Cited by 571
Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice.
Huang, M., Lou, Y.-R., Ma, W., Newmark, H. L., Reuhl, K. R., & Conney, A. H. (1994) · PubMed · Cited by 544
NF-κB, chemokine gene transcription and tumour growth
Richmond, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri887 · Cited by 523
Reddy, B. S., Hirose, Y., Lubet, R. A., Steele, V. E., Kelloff, G. J., Paulson, S. K., Seibert, K., & Rao, C. V. (2000) · PubMed · Cited by 457
Garcea, G., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., Gescher, A. J., & Berry, D. P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601623 · Cited by 425
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells
Kuo, M.-L., Huang, T.-S., & Lin, J.-K. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(96)00032-4 · Cited by 404
Curcumin Is an In Vivo Inhibitor of Angiogenesis
Arbiser, J. L., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M.-T., Fisher, C., Flynn, E., & Byers, H. R. (1998) · Molecular Medicine · doi:10.1007/bf03401744 · Cited by 402
Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines
Mehta, K., Pantazis, P., McQueen, T., & Aggarwal, B. B. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199706000-00010 · Cited by 347
Perspectives on Cancer Chemoprevention Research and Drug Development
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61026-x · Cited by 317
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
Yip-Schneider, M. T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.139 · Cited by 292
Li, L., Aggarwal, B. B., Shishodia, S., Abbruzzese, J., & Kurzrock, R. (2004) · Cancer · doi:10.1002/cncr.20605 · Cited by 289
Self-citationKim, J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.81 · Cited by 285
The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications
Ciechanover, A. J., Orian, A., & Schwartz, A. L. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(2000)77:34+<97::aid-jcb16>3.0.co;2-z · Cited by 283
Huang, M.-N., Wang, Z. Y., Georgiadis, C. A., Laskin, J. D., & Conney, A. H. (1992) · Carcinogenesis · doi:10.1093/carcin/13.11.2183 · Cited by 262
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis
Chuang, S. E. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.331 · Cited by 253
Han, S.-S., Chung, S.-T., Robertson, D. A., Ranjan, D., & Bondada, S. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4769 · Cited by 207
Inhibitory effect of dietary curcumin on skin carcinogenesis in mice
Limtrakul, P., Lipigorngoson, S., Namwong, O., Apisariyakul, A., & Dunn, F. W. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00187-0 · Cited by 194
Huang, M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1697 · Cited by 192
Chen, H., Zhang, Z., Zhang, Y.-L., & Zhou, D. (1999) · PubMed · Cited by 187
Conney, A. H., Lysz, T., Ferraro, T., Abidi, T. F., Manchand, P. S., Laskin, J. D., & Huang, M.-T. (1991) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(91)90025-h · Cited by 182
Willett, W. C. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00822.x · Cited by 178
Tanaka, T., Makita, H., Ohnishi, M., Hirose, Y., Wang, A., Mori, H., Satoh, K., Hara, A., & Ogawa, H. (1994) · PubMed · Cited by 178
Huang, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.1.83 · Cited by 163
Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells
Korutla, L., & Kumar, R. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90299-2 · Cited by 155
Piwocka, K., Zabłocki, K., Wieckowski, M. R., Skierski, J., Feiga, I., Szopa, J., Drela, N., Wojtczak, L., & Sikora, E. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4480 · Cited by 135
Hidaka, H., Ishiko, T., Furuhashi, T., Kamohara, H., Suzuki, S., Miyazaki, M., Ikeda, O., Mita, S., Setoguchi, T., & Ogawa, M. (2002) · Cancer · doi:10.1002/cncr.10812 · Cited by 124
NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells
Xiong, H. Q., Abbruzzese, J. L., Lin, E. H., Wang, L., Zheng, L., & Xie, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11562 · Cited by 113
Lu, Y.-P., Chang, R. L., Lou, Y.-R., Huang, M., Newmark, H. L., Reuhl, K. R., & Conney, A. H. (1994) · Carcinogenesis · doi:10.1093/carcin/15.10.2363 · Cited by 113
Molecular Regulation of Constitutive Expression of Interleukin-8 in Human Pancreatic Adenocarcinoma
Le, X., Shi, Q., Wang, B., Xiong, Q., Qian, C., Peng, Z., Li, X., Tang, H., Abbruzzese, J. L., & Xie, K. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050198372 · Cited by 94
(2001) · PubMed
Cited by
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., & Zhang, H.-G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,572
Metadata
- Authors
- Li, L., Braiteh, F. S., & Kurzrock, R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-08-09
- Volume
- 104
- Issue
- 6
- Pages
- 1322-1331
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1664719478
- Cited by
- 644
- References
- 45
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.